NASDAQ:LCAA L Catterton Asia Acquisition (LCAA) Stock Price, News & Analysis → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free LCAA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$12.10▼$16.5550-Day Range$8.95▼$13.5152-Week Range$8.59▼$16.55Volume107,500 shsAverage Volume191,642 shsMarket Capitalization$391.06 millionP/E Ratio337.83Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisEarningsHeadlinesOwnershipShort InterestSocial MediaStock AnalysisEarningsHeadlinesOwnershipShort InterestSocial Media Get L Catterton Asia Acquisition alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About L Catterton Asia Acquisition Stock (NASDAQ:LCAA)L Catterton Asia Acquisition Corp does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on acquiring business in the consumer technology sectors in Asia. L Catterton Asia Acquisition Corp was incorporated in 2021 and is headquartered in Singapore.Read More Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> LCAA Stock News HeadlinesApril 10, 2024 | americanbankingnews.comL Catterton Asia Acquisition (NASDAQ:LCAA) Shares Up 2.4%February 23, 2024 | prnewswire.comLotus Technology Celebrates Public Listing on NasdaqApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.February 23, 2024 | reuters.comEV maker Lotus Tech closes up modestly in Nasdaq debut after SPAC mergerFebruary 22, 2024 | prnewswire.comLotus Tech and L Catterton Asia Acquisition Corp Complete Business CombinationSeptember 8, 2023 | benzinga.comLotus Electric GT Emeya To Go Into Production Next YearJanuary 31, 2023 | financialpost.comEV maker Lotus Tech to go public in the U.S. via deal with L Catterton SPACSee More Headlines Receive LCAA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for L Catterton Asia Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/19/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorUnclassified Industry Holding & other investment offices Sub-IndustryN/A Current SymbolNASDAQ:LCAA CUSIPN/A CIK1841024 Webwww.lcaac.com Phone65-6672-7600FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.04 Trailing P/E Ratio337.83 Forward P/E RatioN/A P/E GrowthN/ANet Income$10.84 million Net MarginsN/A Pretax MarginN/A Return on Equity-4.09% Return on Assets0.33% Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$1.51 per share Price / Cash Flow8.93 Book Value($2.02) per share Price / Book-6.69Miscellaneous Outstanding Shares28,946,000Free Float28,885,000Market Cap$391.06 million OptionableNot Optionable Beta0.01 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Chintamani Aniruddha Bhagat (Age 55)Co-CEO & Chairman Mr. Yue Chen (Age 47)Co-CEO & Director Mr. Howard SteynPresidentKey CompetitorsNabors Energy Transition Corp. IINASDAQ:NETDWarburg Pincus Capital Co. I-ANYSE:WPCARigel Resource AcquisitionNYSE:RRACPower & Digital Infrastructure Acquisition IINASDAQ:XPDBInflection Point Acquisition Corp. IINASDAQ:IPXXView All CompetitorsInstitutional OwnershipWestchester Capital Management LLCBought 71,275 shares on 2/15/2024Ownership: 3.725%Berkley W R CorpBought 176,715 shares on 2/15/2024Ownership: 3.583%Glazer Capital LLCSold 1,043,569 shares on 2/15/2024Ownership: 2.729%Flow State Investments L.P.Bought 650,000 shares on 2/15/2024Ownership: 2.246%Crystalline Management Inc.Sold 50,000 shares on 2/12/2024Ownership: 0.345%View All Institutional Transactions This page (NASDAQ:LCAA) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIYour Money is Not SafeAmerican AlternativeHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceSHOCKING Crypto Leak…Crypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding L Catterton Asia Acquisition Corp Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.